SCHEMBL6169740

SCHEMBL6169740

O=C1N(c2ccccc2)C(=S)NC1(c1ccccc1)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 7/20 0.69
MGLL Q99685 1/20 0.44
FAAH O00519 1/20 0.42
GRK5 P34947 1/20 0.41
TYRO3 Q06418 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP13 P45452 1/20 0.40
NTRK1 P04629 1/20 0.40
IGF1R P08069 1/20 0.40
FGFR1 P11362 1/20 0.40
NTRK3 Q16288 1/20 0.40
NTRK2 Q16620 1/20 0.40
LMNA P02545 1/20 0.39
PSMB5 P28074 1/20 0.38
PIM1 P11309 1/20 0.38
PSMB1 P20618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167711 0.83 CNR1 (0.50) CNR1MGLLGRK5TYRO3DYRK1B
SCHEMBL6169639 0.80 CNR1 (0.47) CNR1MGLLGRK5TYRO3DYRK1B
SCHEMBL6168712 0.76 CNR1 (0.46) CNR1MGLLGRK5TYRO3DYRK1B
SCHEMBL6168870 0.76 GAA (0.46) CNR1MGLLMMP2MMP3MMP9
SCHEMBL6169738 0.75 CNR1 (0.43) CNR1MGLLMMP2MMP3MMP9
SCHEMBL4519510 0.73 BACE1 (0.44) FAAHNTRK1IGF1RFGFR1NTRK2
SCHEMBL6167462 0.73 CNR1 (0.41) CNR1MGLLMMP2MMP3MMP9
SCHEMBL6168079 0.73 LMNA (0.47) CNR1MGLLMMP2MMP3MMP9
SCHEMBL6168455 0.73 PGR (0.41) CNR1MGLLFAAHMMP2MMP3
SCHEMBL6167893 0.72 ELANE (0.45) CNR1MGLLMMP2MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed